SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-124500
Filing Date
2023-04-28
Accepted
2023-04-28 08:24:50
Documents
5
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d502404ddef14a.htm DEF 14A 614130
2 GRAPHIC g502404dsp64.jpg GRAPHIC 3973
3 GRAPHIC g502404g40p40.jpg GRAPHIC 108387
4 GRAPHIC g502404g41p41.jpg GRAPHIC 115132
5 GRAPHIC g502404g53e52.jpg GRAPHIC 28306
  Complete submission text file 0001193125-23-124500.txt   965205
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36483 | Film No.: 23860478
SIC: 8071 Services-Medical Laboratories